Search research articles
Contact Us
Filters
Showing results (41-50 of 172) with videos related to
Page
of 18
Sort By:
Oncotarget
|
September 17, 2017
Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy
Ernestina Marianna De Francesco, Marcello Maggiolini, Herbert B Tanowitz, et al.
Computer Methods and Programs in Biomedicine
|
April 25, 2025
Federated Learning in radiomics: A comprehensive meta-survey on medical image analysis
Asaf Raza, Antonella Guzzo, Michele Ianni, et al.
Cancer Research
|
September 10, 2009
Role of cyclic AMP response element-binding protein in insulin-like growth factor-i receptor up-regulation by sex steroids in prostate cancer cells
Marco Genua, Giuseppe Pandini, Diego Sisci, et al.
Expert Opinion on Therapeutic Targets
|
June 28, 2022
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress
Ernestina Marianna De Francesco, Francesca Cirillo, Veronica Vella, et al.
Molecular and Cellular Endocrinology
|
February 7, 2012
17β-Estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocyte-derived cell line
Adele Chimento, Rosa Sirianni, Ivan Casaburi, et al.
Cells
|
February 25, 2023
Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer
Marilena Kampa, Rosamaria Lappano, Fedora Grande, et al.
Future Medicinal Chemistry
|
April 16, 2015
Identification of two benzopyrroloxazines acting as selective GPER antagonists in breast cancer cells and cancer-associated fibroblasts
Marcello Maggiolini, Maria Francesca Santolla, Silvia Avino, et al.
Molecular and Cellular Endocrinology
|
February 9, 2010
Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells
Rosamaria Lappano, Camillo Rosano, Paola De Marco, et al.
Breast Cancer Research : BCR
|
August 17, 2013
HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs)
Ernestina Marianna De Francesco, Rosamaria Lappano, Maria Francesca Santolla, et al.
Plos One
|
August 17, 2013
GPER mediates cardiotropic effects in spontaneously hypertensive rat hearts
Ernestina Marianna De Francesco, Tommaso Angelone, Teresa Pasqua, et al.
Page
of 18
Search research articles
Search
Showing results (41-50 of 172) with videos related to
Sort By:
Page
of 18
Oncotarget
|
September 17, 2017
Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy
Ernestina Marianna De Francesco, Marcello Maggiolini, Herbert B Tanowitz, et al.
Computer Methods and Programs in Biomedicine
|
April 25, 2025
Federated Learning in radiomics: A comprehensive meta-survey on medical image analysis
Asaf Raza, Antonella Guzzo, Michele Ianni, et al.
Cancer Research
|
September 10, 2009
Role of cyclic AMP response element-binding protein in insulin-like growth factor-i receptor up-regulation by sex steroids in prostate cancer cells
Marco Genua, Giuseppe Pandini, Diego Sisci, et al.
Expert Opinion on Therapeutic Targets
|
June 28, 2022
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress
Ernestina Marianna De Francesco, Francesca Cirillo, Veronica Vella, et al.
Molecular and Cellular Endocrinology
|
February 7, 2012
17β-Estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocyte-derived cell line
Adele Chimento, Rosa Sirianni, Ivan Casaburi, et al.
Cells
|
February 25, 2023
Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer
Marilena Kampa, Rosamaria Lappano, Fedora Grande, et al.
Future Medicinal Chemistry
|
April 16, 2015
Identification of two benzopyrroloxazines acting as selective GPER antagonists in breast cancer cells and cancer-associated fibroblasts
Marcello Maggiolini, Maria Francesca Santolla, Silvia Avino, et al.
Molecular and Cellular Endocrinology
|
February 9, 2010
Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells
Rosamaria Lappano, Camillo Rosano, Paola De Marco, et al.
Breast Cancer Research : BCR
|
August 17, 2013
HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs)
Ernestina Marianna De Francesco, Rosamaria Lappano, Maria Francesca Santolla, et al.
Plos One
|
August 17, 2013
GPER mediates cardiotropic effects in spontaneously hypertensive rat hearts
Ernestina Marianna De Francesco, Tommaso Angelone, Teresa Pasqua, et al.
Page
of 18